OR

Browse By

Double blind, placebo controlled, parallel group study to compare the effect of Orlistat (Xenical) and placebo on the overall coronary heart disease risk in obese patients with one or more cardiovascu (1998–2001)

Abstract:
Double blind, placebo controlled, parallel group study to compare the effect of Orlistat (Xenical) and placebo on the overall coronary heart disease risk in obese patients with one or more cardiovascular risk factor
Grant type:
Roche Products Pty Ltd
Funded by:
Roche Products Pty Ltd